Introduction
Most hormone therapy practitioners spend enormous energy building their clinics but very little time thinking about how they will eventually transition out of them. Yet planning your exit—whether through sale, partnership, transition to a part-time role, or practice succession—is one of the most important long-term strategic activities a clinic owner can undertake. The decisions you make in building your clinic today directly determine what options are available to you when you’re ready to exit. This guide covers the key exit strategies and how to build toward them.
Why Exit Planning Matters from Day One
Exit planning is not something you do at the end of your career—it is something you build toward from the beginning. The structural decisions you make now (business entity, documentation, systemization, revenue model) determine your clinic’s salability and value years from now. Clinics that are owner-dependent, underdocumented, and operating on informal arrangements are nearly impossible to sell. Clinics built as scalable, systematic businesses with recurring revenue and strong teams are highly valuable and sellable.
Practice Sale: Valuation Basics
Hormone therapy clinic valuations typically range from 1-4x annual EBITDA (earnings before interest, taxes, depreciation, and amortization), depending on factors like: practice size and growth trajectory, revenue mix and recurring revenue percentage, owner dependency, staff quality and retention, clinical protocols and systems, patient demographics and retention rates, and local market factors. A well-built clinic with strong recurring revenue and minimal owner dependency can command premium multiples.
The Management Services Organization (MSO) Model
One increasingly popular exit and scaling strategy for hormone therapy clinics is the MSO model. In this structure, you separate the clinical practice (owned by a licensed provider) from the non-clinical business assets (brand, technology, management infrastructure) owned by the MSO. The MSO can be partially or wholly sold to investors while the clinical practice remains clinician-owned. This structure addresses corporate practice of medicine restrictions while enabling outside investment and eventual partial exit.
Bringing On a Partner
Adding a clinical or business partner is one of the most common transitions for growing hormone clinics. A clinical partner who shares ownership provides succession coverage, reduces owner burnout, and enables practice growth beyond one provider’s capacity. Structure partnership agreements carefully—including buy-out provisions, decision-making authority, profit sharing, and non-compete terms. Work with a healthcare attorney to draft a comprehensive partnership agreement before bringing anyone on as an owner.
Transition to a Part-Time or Advisory Role
Some practitioners want to reduce their clinical workload gradually rather than exit completely. Building a practice that employs other clinical providers, operates with strong systems, and generates revenue without your daily involvement creates the optionality to step back while maintaining income and involvement. This “semi-retirement” model is particularly viable for practitioners who have built strong team cultures and documented operational systems.
Conclusion
Every hormone therapy clinic owner will eventually need an exit strategy—whether by choice or necessity. The practitioners who think about exit from the beginning build better businesses, achieve better outcomes for their patients and staff, and ultimately realize far greater value from the work they’ve invested. Build as if you’ll own your clinic forever, but plan as if you’ll be selling it tomorrow. That combination produces the most valuable, most resilient practices.